Creative Planning’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.56M | Buy |
|
|||||
|
2025
Q2 | $1.79M | Buy |
|
|||||
|
2025
Q1 | $1.2M | Sell |
|
|||||
|
2024
Q4 | $2.66M | Buy |
|
|||||
|
2024
Q3 | $1.5M | Buy |
|
|||||
|
2024
Q2 | $1.59M | Buy |
|
|||||
|
2024
Q1 | $1.59M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $929K | Buy |
|
|||||
|
2023
Q2 | $700K | Sell |
|
|||||
|
2023
Q1 | $761K | Buy |
|
|||||
|
2022
Q4 | $814K | Sell |
|
|||||
|
2022
Q3 | $776K | Buy |
|
|||||
|
2022
Q2 | $501K | Buy |
|
|||||
|
2022
Q1 | $379K | Sell |
|
|||||
|
2021
Q4 | $345K | Buy |
|
|||||
|
2021
Q3 | $377K | Buy |
|
|||||
|
2021
Q2 | $355K | Sell |
|
|||||
|
2021
Q1 | $380K | Sell |
|
|||||
|
2020
Q4 | $604K | Buy |
|
|||||
|
2020
Q3 | $579K | Buy |
|
|||||
|
2020
Q2 | $679K | Buy |
|
|||||
|
2020
Q1 | $471K | Sell |
|
|||||
|
2019
Q4 | $591K | Buy |
|
|||||
|
2019
Q3 | $477K | Buy |
|
|||||
|
2019
Q2 | $445K | Sell |
|
|||||
|
2019
Q1 | $474K | Buy |
|
|||||
|
2018
Q4 | $380K | Buy |
|
|||||
|
2018
Q3 | $651K | Buy |
|
|||||
|
2018
Q2 | $493K | Buy |
|
|||||
|
2018
Q1 | $414K | Buy |
|
|||||
|
2017
Q4 | $385K | Sell |
|
|||||
|
2017
Q3 | $306K | Sell |
|
|||||
|
2017
Q2 | $240K | Sell |
|
|||||
|
2017
Q1 | $232K | Sell |
|
|||||
|
2016
Q4 | $215K | Buy |
|
|||||
|
2016
Q3 | $270K | Buy |
|
|||||
|
2016
Q2 | $241K | Hold |
|
|||||
|
2016
Q1 | $210K | Sell |
|
|||||
|
2015
Q4 | $605K | Buy |
|
|||||
|
2015
Q3 | $28K | Sell |
|
|||||
|
2015
Q2 | $1.28M | Buy |
|
|||||
|
2015
Q1 | $12K | Hold |
|
|||||
|
2014
Q4 | $7K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $8K | Hold |
|
|||||
|
2013
Q4 | $5K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $60K | Buy |
|